|
Volumn 10, Issue 5, 2005, Pages
|
Bisphosphonate safety and tolerability.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
BONE TUMOR;
BREAST TUMOR;
DRUG ADMINISTRATION;
DRUG EFFECT;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY;
MALE;
METASTASIS;
MORBIDITY;
NOTE;
ORAL DRUG ADMINISTRATION;
PATHOLOGY;
PATIENT COMPLIANCE;
PROSTATE TUMOR;
RISK FACTOR;
ADMINISTRATION, ORAL;
BONE NEOPLASMS;
BREAST NEOPLASMS;
DIPHOSPHONATES;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
KIDNEY;
MALE;
MORBIDITY;
PATIENT COMPLIANCE;
PROSTATIC NEOPLASMS;
RISK FACTORS;
MLCS;
MLOWN;
|
EID: 18444384138
PISSN: 10837159
EISSN: None
Source Type: Journal
DOI: 10.1634/theoncologist.10-5-317 Document Type: Note |
Times cited : (4)
|
References (0)
|